UPDATE : Tuesday, October 15, 2019
상단여백
Novo Nordisk's Ryzodeg leads Korean mixed insulin market by Lee Han-soo 2019-09-09 14:18
PARP inhibitors to show intense rivalry at ESMO 2019 by Kim Yun-mi 2019-09-09 11:56
Ildong to sell GSK’s influenza treatment by Lee Han-soo 2019-09-06 17:02
Nobel laureate Honjo anticipates best combo in immunotherapies by Jeong Sae-im 2019-09-06 16:29
Philadelphia Science Center to help Korean diagnostic firms enter US market by Lee Han-soo 2019-09-06 16:26
라인
‘No antibiotic works for patients with multidrug-resistant infections’ by Kim Yun-mi 2019-09-06 15:11
Yuhan to expand biz scope to central nervous system disease by Jeong Sae-im 2019-09-06 14:56
Drug safety institute conducts APEC program by Lee Han-soo 2019-09-06 14:53
Seoul Pharmaceutical to export erectile dysfunction treatment to Taiwan by Lee Han-soo 2019-09-05 17:04
Lilly’s migraine treatment Emgality lands in Korea by Lee Hye-seon 2019-09-05 16:24
라인
SNUBH researchers find new disease that causes acute dizziness by Lee Han-soo 2019-09-05 16:21
Korean doctors categorize 12 cases to refuse treatment by Song Soo-youn 2019-09-05 16:19
Daewoong, Medytox squabble over appraisal of additional spore for Nabota by Lee Han-soo 2019-09-05 14:35
SNUH to build smart clinical trial platform by Lee Han-soo 2019-09-05 14:35
‘Government is doing best to relieve pain of atopic dermatitis patients’ by Kim Yun-mi 2019-09-05 11:48
라인
Chung-Ang, Hyundae General Hospital to cooperate with Astana Medical University in Kazakhstan by Park Gi-taek 2019-09-04 17:12
Myongji to install 1st multi-person hyperbaric oxygen therapy chamber in Seoul by Lee Han-soo 2019-09-04 17:06
[News analysis] Takeda Korea’s merger with Shire has to surmount big hurdle; labor union by Lee Han-soo 2019-09-04 17:06
JW Pharmaceutical acquires Vietnamese drugmaker by Lee Han-soo 2019-09-04 15:16
Local hospitals develop humanized antibody to treat lupus nephritis by Lee Han-soo 2019-09-04 15:15
여백
여백
여백
Back to Top